Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2020

01-09-2020 | Fluconazole | Review

A decade after the emergence of Candida auris: what do we know?

Author: Amira ElBaradei

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2020

Login to get access

Abstract

Candida auris is a remarkable emerging pathogen. It has emerged separately, yet simultaneously in different parts of the world, establishing four phylogenetic and geographic distinct clades with a potential fifth clade that was recently reported. C. auris is often perceived as a pathogen in disguise, due to its frequent misidentification and its immune evasion. On the other hand, many of the recovered isolates are multidrug-resistant. In fact, some of these isolates are resistant to the three main antifungal classes: echinocandins, azoles, and polyenes. Moreover, C. auris has the ability to persist and survive on different objects for a long time, aided by different adhering mechanisms including aggregation and biofilm formation, thereby causing outbreaks of invasive infections in hospital settings. However, C. auris ability to maintain its pathogenicity at high temperatures remains among its most unique properties. This is why C. auris represents a challenging threat, and more studies are needed to meet this challenge. This review highlights different characteristics of this emerging yeast with emphasis on its antifungal resistance, its ability to persistent on different surfaces, and its immune evasion capability.
Literature
9.
go back to reference Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134–140. https://doi.org/10.1093/cid/ciw691CrossRefPubMed Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134–140. https://​doi.​org/​10.​1093/​cid/​ciw691CrossRefPubMed
13.
go back to reference Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, Lee SY, Chun S, Lee JH, Choi HJ, Kee SJ, Kim SH, Shin MG (2019) Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol 57(4). https://doi.org/10.1128/JCM.01624-18 Kwon YJ, Shin JH, Byun SA, Choi MJ, Won EJ, Lee D, Lee SY, Chun S, Lee JH, Choi HJ, Kee SJ, Kim SH, Shin MG (2019) Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol 57(4). https://​doi.​org/​10.​1128/​JCM.​01624-18
22.
go back to reference Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53(6):1823–1830. https://doi.org/10.1128/JCM.00367-15CrossRefPubMedPubMedCentral Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53(6):1823–1830. https://​doi.​org/​10.​1128/​JCM.​00367-15CrossRefPubMedPubMedCentral
28.
go back to reference Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A (2016) Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses 59(8):535–538. https://doi.org/10.1111/myc.12519CrossRefPubMed Girard V, Mailler S, Chetry M, Vidal C, Durand G, van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A (2016) Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses 59(8):535–538. https://​doi.​org/​10.​1111/​myc.​12519CrossRefPubMed
29.
go back to reference Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F, Govender NP, Colombo AL, Meis JF, Chowdhary A (2016) Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect 22(3):277 e271–277 e279. https://doi.org/10.1016/j.cmi.2015.10.022CrossRef Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F, Govender NP, Colombo AL, Meis JF, Chowdhary A (2016) Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect 22(3):277 e271–277 e279. https://​doi.​org/​10.​1016/​j.​cmi.​2015.​10.​022CrossRef
32.
go back to reference Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP (2018) Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol 56(12). https://doi.org/10.1128/JCM.01337-18 Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP (2018) Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol 56(12). https://​doi.​org/​10.​1128/​JCM.​01337-18
33.
go back to reference Leach L, Russell A, Zhu Y, Chaturvedi S, Chaturvedi V (2019) A rapid and automated sample-to-result Candida auris real-time PCR assay for high-throughput testing of surveillance samples with the BD max open system. J Clin Microbiol 57(10). https://doi.org/10.1128/JCM.00630-19 Leach L, Russell A, Zhu Y, Chaturvedi S, Chaturvedi V (2019) A rapid and automated sample-to-result Candida auris real-time PCR assay for high-throughput testing of surveillance samples with the BD max open system. J Clin Microbiol 57(10). https://​doi.​org/​10.​1128/​JCM.​00630-19
34.
go back to reference Lima A, Widen R, Vestal G, Uy D, Silbert S (2019) A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD max system. J Clin Microbiol 57(7). https://doi.org/10.1128/JCM.01604-18 Lima A, Widen R, Vestal G, Uy D, Silbert S (2019) A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD max system. J Clin Microbiol 57(7). https://​doi.​org/​10.​1128/​JCM.​01604-18
40.
go back to reference Khillan VR; Kathuria, S; Chowdhary, A (2014) A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease JMM. Case Rep 1(3) Khillan VR; Kathuria, S; Chowdhary, A (2014) A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease JMM. Case Rep 1(3)
45.
go back to reference Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73(4):891–899. https://doi.org/10.1093/jac/dkx480CrossRefPubMed Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73(4):891–899. https://​doi.​org/​10.​1093/​jac/​dkx480CrossRefPubMed
46.
go back to reference Escandon P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varon C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM (2019) Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis 68(1):15–21. https://doi.org/10.1093/cid/ciy411CrossRefPubMed Escandon P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varon C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM (2019) Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis 68(1):15–21. https://​doi.​org/​10.​1093/​cid/​ciy411CrossRefPubMed
52.
go back to reference Dudiuk C, Berrio I, Leonardelli F, Morales-Lopez S, Theill L, Macedo D, Yesid-Rodriguez J, Salcedo S, Marin A, Gamarra S, Garcia-Effron G (2019) Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. J Antimicrob Chemother 74(8):2295–2302. https://doi.org/10.1093/jac/dkz178CrossRefPubMed Dudiuk C, Berrio I, Leonardelli F, Morales-Lopez S, Theill L, Macedo D, Yesid-Rodriguez J, Salcedo S, Marin A, Gamarra S, Garcia-Effron G (2019) Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. J Antimicrob Chemother 74(8):2295–2302. https://​doi.​org/​10.​1093/​jac/​dkz178CrossRefPubMed
56.
go back to reference Healey KR, Kordalewska M, Jimenez Ortigosa C, Singh A, Berrio I, Chowdhary A, Perlin DS (2018) Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility. Antimicrob Agents Chemother 62(10). https://doi.org/10.1128/AAC.01427-18 Healey KR, Kordalewska M, Jimenez Ortigosa C, Singh A, Berrio I, Chowdhary A, Perlin DS (2018) Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility. Antimicrob Agents Chemother 62(10). https://​doi.​org/​10.​1128/​AAC.​01427-18
59.
go back to reference Charlier C, El Sissy C, Bachelier-Bassi S, Scemla A, Quesne G, Sitterle E, Legendre C, Lortholary O, Bougnoux ME (2016) Acquired flucytosine resistance during combination therapy with caspofungin and flucytosine for Candida glabrata cystitis. Antimicrob Agents Chemother 60(1):662–665. https://doi.org/10.1128/AAC.02265-15CrossRefPubMed Charlier C, El Sissy C, Bachelier-Bassi S, Scemla A, Quesne G, Sitterle E, Legendre C, Lortholary O, Bougnoux ME (2016) Acquired flucytosine resistance during combination therapy with caspofungin and flucytosine for Candida glabrata cystitis. Antimicrob Agents Chemother 60(1):662–665. https://​doi.​org/​10.​1128/​AAC.​02265-15CrossRefPubMed
65.
go back to reference Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M (2017) The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61(5). https://doi.org/10.1128/AAC.02396-16 Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M (2017) The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61(5). https://​doi.​org/​10.​1128/​AAC.​02396-16
76.
go back to reference Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM (2017) Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. Am J Transplant 17(1):296–299. https://doi.org/10.1111/ajt.14121CrossRefPubMed Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM (2017) Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. Am J Transplant 17(1):296–299. https://​doi.​org/​10.​1111/​ajt.​14121CrossRefPubMed
78.
go back to reference Kean R, Delaney C, Sherry L, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R, Williams C, Ramage G (2018) Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere 3 (4). doi:https://doi.org/10.1128/mSphere.00334-18 Kean R, Delaney C, Sherry L, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R, Williams C, Ramage G (2018) Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere 3 (4). doi:https://​doi.​org/​10.​1128/​mSphere.​00334-18
83.
87.
go back to reference Navarro-Arias MJ, Hernandez-Chavez MJ, Garcia-Carnero LC, Amezcua-Hernandez DG, Lozoya-Perez NE, Estrada-Mata E, Martinez-Duncker I, Franco B, Mora-Montes HM (2019) Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist 12:783–794. https://doi.org/10.2147/IDR.S197531CrossRefPubMedPubMedCentral Navarro-Arias MJ, Hernandez-Chavez MJ, Garcia-Carnero LC, Amezcua-Hernandez DG, Lozoya-Perez NE, Estrada-Mata E, Martinez-Duncker I, Franco B, Mora-Montes HM (2019) Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist 12:783–794. https://​doi.​org/​10.​2147/​IDR.​S197531CrossRefPubMedPubMedCentral
88.
go back to reference Pathirana RU, Friedman J, Norris HL, Salvatori O, McCall AD, Kay J, Edgerton M (2018) Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses. Antimicrob Agents Chemother 62(2). https://doi.org/10.1128/AAC.01872-17 Pathirana RU, Friedman J, Norris HL, Salvatori O, McCall AD, Kay J, Edgerton M (2018) Fluconazole-resistant Candida auris is susceptible to salivary histatin 5 killing and to intrinsic host defenses. Antimicrob Agents Chemother 62(2). https://​doi.​org/​10.​1128/​AAC.​01872-17
89.
go back to reference Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, Kindo AJ, Marak RSK, Arora A, Sardana R, Das S, Chhina D, Patel A, Xess I, Tarai B, Singh P, Ghosh A (2017) Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 72(6):1794–1801. https://doi.org/10.1093/jac/dkx034CrossRefPubMed Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, Kindo AJ, Marak RSK, Arora A, Sardana R, Das S, Chhina D, Patel A, Xess I, Tarai B, Singh P, Ghosh A (2017) Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 72(6):1794–1801. https://​doi.​org/​10.​1093/​jac/​dkx034CrossRefPubMed
94.
go back to reference Bishop LC, Guy R, Hoffman; P.; Jeffery K.; Jeffery-Smith A.; Brown, C. (2017) Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. Public Health England. Updated August 2017 Bishop LC, Guy R, Hoffman; P.; Jeffery K.; Jeffery-Smith A.; Brown, C. (2017) Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. Public Health England. Updated August 2017
95.
go back to reference European Centre for Disease Prevention and Control. Candida auris in healthcare settings—Europe. European Centre for Disease Prevention and Control (2016). Stockholm European Centre for Disease Prevention and Control. Candida auris in healthcare settings—Europe. European Centre for Disease Prevention and Control (2016). Stockholm
Metadata
Title
A decade after the emergence of Candida auris: what do we know?
Author
Amira ElBaradei
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Keyword
Fluconazole
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03886-9

Other articles of this Issue 9/2020

European Journal of Clinical Microbiology & Infectious Diseases 9/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.